Onconetix, Inc., a pharmaceutical company with a market capitalization of just $3.98 million, has received a notification ...

Onconetix, Inc. (NASDAQ:ONCO), a pharmaceutical company with a market capitalization of $4.48 million, has reached a ...

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6 ...

Onconetix, Inc. announced that it received a notice from Nasdaq on December 6, 2024, regarding its failure to file the Quarterly Report on Form 10-Q for the period ending September 30, 2024 ...

EST Onconetix (ONCO) files to sell 50M shares of common stock for holdersInvest with Confidence: Follow TipRanks' Top Wall Street ...

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ...

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...